Benefits
Appetite Control / Reduced Food Intake
2024 Nexira in vivo study showed 47% average reduction in food intake at equivalent human use level (3 g/day) over 4 weeks. Mechanism: significant slowing of gastric emptying creating prolonged fullness.
Rapid Satiety Onset
In simulated ingestion conditions, Carolean™ achieves 70% of maximum viscosity within 15 minutes of ingestion — faster than recognized market satiety ingredients. Quicker satiety culmination than other appetite control ingredients.
Gastric Emptying Delay
Same Nexira study demonstrated significant slowing of gastric emptying in both single-dose and prolonged-use scenarios. Foundation for sustained satiety effects.
Synergistic Action
Carob (galactomannan) and Nopal (soluble fiber/mucilage) work synergistically — different fiber types with complementary water-binding and gel-forming properties create enhanced satiety effect vs either alone.
Weight Management Adjunct
Reduced food intake supports caloric deficit; useful adjunct in comprehensive weight management. Effects via appetite mechanism rather than metabolism.
Mechanism of action
Gastric Emptying Delay
Soluble fibers from carob and nopal create gel-like matrix in stomach that slows gastric emptying — prolongs feeling of fullness, reduces subsequent food intake. Foundation for appetite control.
Carob Galactomannan
Carob (locust bean gum) provides galactomannan — soluble fiber with strong water-binding and gel-forming properties. Mannose:galactose ratio of 4:1.
Nopal Soluble Fiber and Mucilage
Nopal provides additional soluble fiber, mucilage, and pectin compounds — complementary to carob with different viscosity profile.
Patent-Pending Synergistic Formulation
Specific ratios and processing developed by Nexira to optimize satiety kinetics — patent-pending status reflects novel formulation approach. Effects greater than additive of individual components.
Clinical trials
In vivo study of Carolean™ at 3 g/day equivalent for 4 weeks on appetite, gastric emptying, and food intake.
Animal in vivo model.
Significant slowing of gastric emptying in single and prolonged use; 47% average reduction in food intake. Established mechanism and dose-response.
Simulated ingestion conditions (temperature, pH) measuring viscosity development over time.
In vitro / simulated GI conditions.
70% of maximum viscosity reached within 15 minutes — faster than market standards. Established rapid satiety onset advantage.